Voyageur Pharmaceuticals Ltd.
VYYRF
$0.10
$0.0110.23%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -102.10% | -99.32% | -62.45% | -57.66% | -21.15% |
| Total Depreciation and Amortization | -33.33% | -30.77% | -28.57% | -26.67% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 83.02% | 69.25% | 77.46% | 72.48% | 44.52% |
| Change in Net Operating Assets | -114.48% | -132.69% | -120.11% | -87.71% | 784.24% |
| Cash from Operations | -817.84% | -731.17% | -260.56% | -102.70% | 69.45% |
| Capital Expenditure | -59.28% | -27.74% | 9.23% | 2.29% | 6.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -59.28% | -27.74% | 9.23% | 2.29% | 6.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 570.19% | 567.63% | 234.63% | 216.94% | -58.96% |
| Repurchase of Common Stock | -- | -- | -- | 65.85% | 65.85% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -158.80% | 1,182.01% | 1,419.72% | 1,867.98% | 317.48% |
| Cash from Financing | 397.39% | 671.85% | 324.41% | 313.53% | -44.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.95% | 19,761.76% | 416.69% | 190.42% | 683.65% |